Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial.
Brüll V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig G, Müller C, Langguth P, Alteheld B, Fimmers R, Naaf S, Zimmermann BF, Stehle P, Egert S. Brüll V, et al. Among authors: burak c. Br J Nutr. 2015 Oct 28;114(8):1263-77. doi: 10.1017/S0007114515002950. Epub 2015 Sep 2. Br J Nutr. 2015. PMID: 26328470 Free PMC article. Clinical Trial.
Acute intake of quercetin from onion skin extract does not influence postprandial blood pressure and endothelial function in overweight-to-obese adults with hypertension: a randomized, double-blind, placebo-controlled, crossover trial.
Brüll V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig G, Müller C, Langguth P, Alteheld B, Fimmers R, Stehle P, Egert S. Brüll V, et al. Among authors: burak c. Eur J Nutr. 2017 Apr;56(3):1347-1357. doi: 10.1007/s00394-016-1185-1. Epub 2016 Feb 29. Eur J Nutr. 2017. PMID: 26924303 Clinical Trial.
No effects of quercetin from onion skin extract on serum leptin and adiponectin concentrations in overweight-to-obese patients with (pre-)hypertension: a randomized double-blinded, placebo-controlled crossover trial.
Brüll V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig G, Müller C, Langguth P, Alteheld B, Fimmers R, Stehle P, Egert S. Brüll V, et al. Among authors: burak c. Eur J Nutr. 2017 Oct;56(7):2265-2275. doi: 10.1007/s00394-016-1267-0. Epub 2016 Jul 16. Eur J Nutr. 2017. PMID: 27423432 Clinical Trial.
PR prolongation as a predictor of atrial fibrillation onset: A state-of-the-art review.
Ali ZS, Bhuiyan A, Vyas P, Miranda-Arboleda AF, Tse G, Bazoukis G, Burak C, Abuzeid W, Lee S, Gupta S, Meghdadi A, Baranchuk A. Ali ZS, et al. Among authors: burak c. Curr Probl Cardiol. 2024 Apr;49(4):102469. doi: 10.1016/j.cpcardiol.2024.102469. Epub 2024 Feb 16. Curr Probl Cardiol. 2024. PMID: 38369207 Free article. Review.
New pattern of atypical advanced interatrial block.
Silvestrini TL, Burak C, Miranda-Arboleda AF, Wesseem O, Alam M, Gupta S, Alemi AA, de March Ronsoni R, da Costa Fontoura SP, Passuelo GG, de Luna AB, Baranchuk A. Silvestrini TL, et al. Among authors: burak c. J Electrocardiol. 2023 Nov-Dec;81:66-69. doi: 10.1016/j.jelectrocard.2023.08.001. Epub 2023 Aug 9. J Electrocardiol. 2023. PMID: 37597502
60 results